Delivery Order SPE2DB22D2214-SPE2DB25FS5ZF
- Not listed
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,067.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Isosorbide Mononitrate 20 mg, a cardiovascular medication used to treat angina. The contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,912.66 firm fixed-price contract is for the supply of Isosorbide Dinitrate 40 mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle...
- The Defense Logistics Agency awarded a $115,560 delivery order to AmerisourceBergen Drug Corporation for 100 bottles of 5 mg Isosorbide Dinitrate tablets. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide pharmaceutical products to DLA locations in Conshohocken, Pennsylvania from September 22 to 25, 2023. AmerisourceBergen will deliver the requested medications as the prime contractor for this order placed under the Agency's Prime...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,177.32 delivery order from the Defense Logistics Agency on September 9, 2025, for 1,000 tablets of Nitrofurantoin Mono-MCR 100 mg. The award, designated as contract number 4569419187, is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $15,173.50 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count units) on September 16, 2025, with completion expected by September 17, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.01 to AmerisourceBergen Drug Corp for the supply of Ivabradine HCl 5 mg tablets (60-count package) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is a child...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5ZFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count) with a ceiling value of $2,079.46. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026 that enables AmerisourceBergen to provide a broad range of medications, medical supplies, and vaccines to support military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime vendor status with the Defense Logistics Agency to fulfill critical medical procurement needs across the military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains. This delivery order for cardiac medication reflects the company's role as a essential vendor supporting the Defense Health Agency and other government healthcare systems through flexible and scalable contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/29/25 |